Abstract
BackgroundWe have reported that abatacept (ABA) treatment suppressed T cell activation and reduced plasma levels of interleukin (IL)-6 in rheumatoid arthritis (RA) patients. Anti-cyclic citrullinated peptide antibodies (ACPA) are highly...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
